Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Oncology Reports|May 21, 2011
Fotemustine in patients with relapsing malignant gliomas - a phase-ii trialC Punt, L Stamatakis, B Gerard
European Journal of Cancer & Clinical Oncology|July 1, 1987
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreasJ Wils, H Bleiberg, O Dalesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Dose-finding study of tropisetron in cisplatin-induced nausea and vomitingS J Van Belle, L Stamatakis, H Bleiberg, et al.
Endoscopy|September 1, 1979
Endoscopic appearance of irradiated gastric mucosaL I De Sagher, B Van den Heule, P Van Houtte, et al.
Spinal Cord|April 23, 1999
Upper extremity pain after spinal cord injuryM Dalyan, D D Cardenas, B Gerard
Anti-Cancer Drugs|July 23, 2004
Treatment of advanced digestive non-colon cancer with a weekly 24-h infusion of high-dose 5-fluorouracil modulated by folinic acid and cisplatin: an easy-to-use and well-tolerated combinationT Delaunoit, R Maréchal, A Hendlisz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomasF X Caroli-Bosc, J L Van Laethem, P Michel, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative GroupA J Lacave, J Wils, E Diaz-Rubio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicityS Aamdal, B Gerard, T Bohman, et al.
Melanoma Research|December 1, 1992
Fotemustine--an advance in the treatment of metastatic malignant melanomaO Merimsky, M Inbar, B Gerard, et al.
Pageof 15